Physician profile
Asad Omar
NPI 1376850651
$1,616.84
in general payments reported to CMS, 2019-2025
20 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $88.87 · 2021: $348 · 2022: $131 · 2023: $219 · 2024: $266 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $631.89 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.44 | 2019-2023 | Ofev |
| Medtronic, INC. | $139.70 | 2023 | Corevalve Evolut R |
| Mylan Specialty L.P. | $138.17 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $94.98 | 2019-2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $69.58 | 2019-2023 | Tezspire |
| Inogen, INC. | $67.04 | 2024 | |
| Insmed, INC. | $48.99 | 2024-2025 | Arikayce |
| Novartis Pharmaceuticals Corporation | $34.06 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $29.00 | 2021 | |
| Sunovion Pharmaceuticals INC. | $25.72 | 2019 | |
| Viatris Specialty LLC | $24.54 | 2025 | Yupelri |
| Mallinckrodt Enterprises LLC | $23.90 | 2019 | |
| Blueprint Medicines Corporation | $23.44 | 2024 | Ayvakit |
| Alexion Pharmaceuticals, INC. | $21.83 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $19.30 | 2024 | |
| Gilead Sciences, INC. | $16.21 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 2019 | |
| Philips North America LLC | $15.68 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Omar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.